Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Cimetidine 400mg tablets
0103010D0AAABAB
|
Cimetidine | Cimetidine | Gastro-Intestinal System | 15,600 |
|
Cimetidine 200mg tablets
0103010D0AAAAAA
|
Cimetidine | Cimetidine | Gastro-Intestinal System | 2,524 |
|
Cimetidine 200mg/5ml oral solution
0103010D0AAADAD
|
Cimetidine | Cimetidine | Gastro-Intestinal System | 2,038 |
|
Cimetidine 200mg/5ml oral solution sugar free
0103010D0AAALAL
|
Cimetidine | Cimetidine | Gastro-Intestinal System | 1,360 |
|
Cimetidine 800mg tablets
0103010D0AAACAC
|
Cimetidine | Cimetidine | Gastro-Intestinal System | 281 |
|
Tagamet 200mg/5ml syrup
0103010D0BBADAD
|
Tagamet | Cimetidine | Gastro-Intestinal System | 242 |
|
Tagamet 400mg tablets
0103010D0BBABAB
|
Tagamet | Cimetidine | Gastro-Intestinal System | 2 |
|
Acid-Eze 200mg tablets
0103010D0BLAAAA
|
Acid-Eze | Cimetidine | Gastro-Intestinal System | No data available |
|
Acitak 400mg tablets
0103010D0BKAAAB
|
Acitak | Cimetidine | Gastro-Intestinal System | No data available |
|
Cimetidine 100mg tablets
0103010D0AAAKAK
|
Cimetidine | Cimetidine | Gastro-Intestinal System | No data available |
|
Cimetidine 200mg chewable tablets sugar free
0103010D0AAAFAF
|
Cimetidine | Cimetidine | Gastro-Intestinal System | No data available |
|
Cimetidine 200mg/2ml solution for injection ampoules
0103010D0AAAEAE
|
Cimetidine | Cimetidine | Gastro-Intestinal System | No data available |
|
Cimetidine 200mg/5ml oral suspension sugar free
0103010D0AAAGAG
|
Cimetidine | Cimetidine | Gastro-Intestinal System | No data available |
|
Cimetidine 400mg effervescent tablets sugar free
0103010D0AAAIAI
|
Cimetidine | Cimetidine | Gastro-Intestinal System | No data available |
|
Dyspamet 200mg chewable tablets
0103010D0BCAAAF
|
Dyspamet | Cimetidine | Gastro-Intestinal System | No data available |
|
Dyspamet 200mg/5ml oral suspension
0103010D0BCABAG
|
Dyspamet | Cimetidine | Gastro-Intestinal System | No data available |
|
Galenamet 400mg tablets
0103010D0BFABAB
|
Galenamet | Cimetidine | Gastro-Intestinal System | No data available |
|
Peptimax 200 tablets
0103010D0BDAAAA
|
Peptimax | Cimetidine | Gastro-Intestinal System | No data available |
|
Peptimax 400 tablets
0103010D0BDABAB
|
Peptimax | Cimetidine | Gastro-Intestinal System | No data available |
|
Tagadine 400mg tablets
0103010D0BMAAAB
|
Tagadine | Cimetidine | Gastro-Intestinal System | No data available |
|
Tagamet 100 tablets
0103010D0BBAIAK
|
Tagamet | Cimetidine | Gastro-Intestinal System | No data available |
|
Tagamet 200mg tablets
0103010D0BBAAAA
|
Tagamet | Cimetidine | Gastro-Intestinal System | No data available |
|
Tagamet 200mg/2ml solution for injection ampoules
0103010D0BBAEAE
|
Tagamet | Cimetidine | Gastro-Intestinal System | No data available |
|
Tagamet 400mg effervescent tablets
0103010D0BBAGAI
|
Tagamet | Cimetidine | Gastro-Intestinal System | No data available |
|
Tagamet 800mg tablets
0103010D0BBACAC
|
Tagamet | Cimetidine | Gastro-Intestinal System | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.